About this trial
Pediatric nephrolithiasis accounts for approximately 2-3% of all stone disease cases, with recent reports indicating a rising prevalence of up to 10.6%. This increasing incidence poses a growing public health concern. The primary objective in managing pediatric renal stones is complete stone clearance while minimizing complications and improving the patient's quality of life.
Eligibility criteria
Qualifiers
Children aged 1 to 18 years .
Presence of a renal stone ≤2 cm in maximum diameter (single or multiple).
Stone located in the renal pelvis and/or calyces.
Normal renal function (based on age-adjusted serum creatinine and/or eGFR).
Disqualifiers
Anatomical abnormalities of the urinary tract (e.g., ureteropelvic junction obstruction, horseshoe kidney).
Bleeding disorders or uncorrected coagulopathy.
Active urinary tract infection at the time of surgery.
Patients with contraindications to general anesthesia.
Trial design
Treatments tested in this trial
- Retrograde Intrarenal Surgery